Our Experimental Medicine Training Initiative recommences after a hiatus following the COVID-19 pandemic and will focus on "Challenges and advances in Next Generation Therapeutics" in a virtual online only event. NOTE there is NO DINNER on this occasion!
This is a joint session between the EMI Training Scheme and the British Pharmacological Society's National Training Event for Clinical Pharmacology trainees. We are delighted to be joined by a number of drug development experts from AstraZeneca.
This training will occur virtually via a Zoom webinar - please register for free and once registered, a Zoom link will be emailed to you.
NOTE: CPD Attendance certificates will ONLY be issued if you attended the event having registered on this website prior to the event and had a confirmation email from us.
Registrations will close at 4pm on 27 Jan 2022.
The Meeting ID will be supplied to all those who register and you will be reminded during the live sessions.
Programme
Day 1 | Friday 28 January 2022
Time
Item
14:00 to 14:05
Welcome and introductions
Dr Joseph Cheriyan, EMI Training Lead and Training Programme Director, Eastern Deanery & Dr Spoorthy Kulkarni, Clinical Pharmacology SpR
14:05 to 14:45
Turning human peptides and proteins into new medicines
Dr Lutz Jermutus, Vice President and Head of Projects, Early Cardiovascular-Renal-Metabolic, AstraZeneca
14:45 to 15:25
Clinical advantages of extended half-life antibodies – two case studies
Dr Philip Ambery, Global Clinical Head, Late phase Cardiovascular-Renal-Metabolic, AstraZeneca
15:25 to 16:05
Self-amplifying RNA, a step-change in nucleotide therapeutics
Dr Claire Dobson
Executive Director, Discovery Sciences, AstraZeneca
16:05 to 16:20
Question & Answer session then Close of meeting
Challenges and advances in next-generation therapeutics
Our Experimental Medicine Training Initiative recommences after a hiatus following the COVID-19 pandemic and will focus on "Challenges and advances in Next Generation Therapeutics" in ...
